Filed before 2025Filed 7 August 2020
Alpine Immune Sciences, Inc. raised $60M
Alpine Immune Sciences, Inc., a biotech company based in Seattle, WA, raised $60M in a new equity round, according to a filing dated 7 August 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 7 August 2020
- Round
- Equity round
- Amount sold
- $60M
- Offering size
- $82.7M
- Investors so far
- 25
- Based in
- Seattle, WA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 91% of the 1,744 tracked raises with an amount filed in 2020, and than 78% of the 152 in biotech.
Alpine Immune Sciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 29 Sep 2021 | New filing | $91M | Another raise |
| 7 Aug 2020 | New filing | $60M | This raise |
| 30 Jan 2019 | New filing | $25.3M | Another raise |
| 25 Nov 2014 | New filing | $30M | Another raise |
More with Frazier Life Sciences on the board
- Enlaza Therapeutics, Inc.$15M
- Sudo Biosciences, Inc.$63.6M
- MBX Biosciences, Inc.$46.7M
- 98point6 Inc.$20.9M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.